Search Results - "Bahary, J"
-
1
Prospective Phase II Trial of Once-weekly Hypofractionated Radiation Therapy for Low-risk Adenocarcinoma of the Prostate: Late Toxicities and Outcomes
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01-06-2016)“…Abstract Aims To report the long-term toxicities and sexual quality of life of a once-weekly hypofractionated radiation therapy schedule for low-risk prostate…”
Get full text
Journal Article -
2
Liquid Embolization Material Reduces the Delivered Radiation Dose: Clinical Myth or Reality?
Published in American journal of neuroradiology : AJNR (01-02-2012)“…To be radiopaque, BAVM embolization products must contain high-atomic-number materials, which may also attenuate photon beams delivered with radiosurgery. This…”
Get full text
Journal Article -
3
Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813
Published in International journal of radiation oncology, biology, physics (01-12-2020)Get full text
Journal Article -
4
Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy
Published in International Journal of Obesity (01-11-2011)“…Objective: We tested the potential role of abdominal visceral (VAT) and subcutaneous (SAT) adipose tissues, waist circumference (WC) and body mass index (BMI)…”
Get full text
Journal Article -
5
Procarbazine, lomustine and vincristine toxicity in low-grade gliomas
Published in Current oncology (Toronto) (01-02-2018)“…Procarbazine, lomustine, and vincristine (pcv) significantly improve survival outcomes in lgg (low-grade gliomas). Administration of pcv to lgg patients…”
Get full text
Journal Article -
6
-
7
-
8
Radiation Therapy Oncology Group (RTOG) 9408: A Secondary Analysis of the Risk of Death From Second Cancers Comparing Whole Pelvic (WP) Radiation Therapy (RT) to Prostate Only (PO) RT and Neoadjuvant Hormonal Therapy (NHT) + RT to RT Alone
Published in International journal of radiation oncology, biology, physics (01-10-2013)Get full text
Journal Article -
9
-
10
-
11
-
12
Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG)
Published in International journal of radiation oncology, biology, physics (01-09-2014)Get full text
Journal Article -
13
-
14
Dose Volume Analysis of Grade 2+ Late GI Toxicity on RTOG 0126 After High-dose 3DCRT or IMRT
Published in International journal of radiation oncology, biology, physics (01-11-2012)Get full text
Journal Article -
15
Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole Brain Radiation Therapy (WBRT) Versus WBRT Plus Stereotactic Radiosurgery (SRS) in Patients With 1-3 Brain Metastases; Poststratified by the Graded Prognostic Assessment (GPA)
Published in International journal of radiation oncology, biology, physics (01-10-2013)Get full text
Journal Article -
16
-
17
Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme
Published in Journal of clinical oncology (13-03-2000)“…This phase II study tested the efficacy and safety of tirapazamine (Sanofi Synthelabo Research, Malvern, PA), a bioreductive agent, in glioblastoma multiforme…”
Get full text
Journal Article -
18
-
19
-
20